Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Avalon Globocare (ALBT)

Avalon Globocare (ALBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,317
  • Shares Outstanding, K 4,252
  • Annual Sales, $ 1,330 K
  • Annual Income, $ -7,900 K
  • EBIT $ -7 M
  • EBITDA $ -5 M
  • 60-Month Beta -0.23
  • Price/Sales 0.94
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.51
  • Most Recent Earnings $-0.06 on 11/14/25
  • Next Earnings Date 03/20/26 [--]
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4200 +21.71%
on 02/23/26
1.5900 -67.85%
on 02/27/26
-0.0349 (-6.39%)
since 02/20/26
3-Month
0.4200 +21.71%
on 02/23/26
1.5900 -67.85%
on 02/27/26
-0.7088 (-58.10%)
since 12/19/25
52-Week
0.4200 +21.71%
on 02/23/26
6.4900 -92.12%
on 03/21/25
-5.8888 (-92.01%)
since 03/20/25

Most Recent Stories

More News
Avalon GloboCare Announces Closing of up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq Rules

FREEHOLD, N.J., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a diversified company focused on the development of precision diagnostic consumer...

ALBT : 0.5150 (-5.50%)
Avalon GloboCare Announces up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq Rules

FREEHOLD, N.J., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a diversified company focused on the development of precision diagnostic consumer...

ALBT : 0.5150 (-5.50%)
This Penny Stock Is Getting a Major Boost From AMD Today. Should You Buy In?

Avalon GloboCare stock skyrocketed today as its subsidiary secured a spot in AMD's AI Developer Program. Here’s why ALBT shares remain super risky to own still in 2026.

ALBT : 0.5150 (-5.50%)
AMD : 201.29 (-1.94%)
Avalon GloboCare’s Subsidiary Accepted into AMD AI Developer Program to Advance Next-Generation Media Infrastructure

FREEHOLD, N.J., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT) , a diversified company focused on the development of precision diagnostic...

ALBT : 0.5150 (-5.50%)
Avalon GloboCare’s Subsidiary Files Third U.S. Provisional Patent for its Catch-Up Generative AI Video Platform

FREEHOLD, N.J., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT) , a diversified company focused on the development of precision diagnostic...

ALBT : 0.5150 (-5.50%)
Avalon GloboCare Eliminates Majority of Debentures Through $2.6 Million Conversion, Strengthening Balance Sheet, Reduces Overhang

Conversion Improves Capital Structure, and Reinforces Nasdaq Compliance, Enhancing Shareholder Value Company Believes That Substantially All of the Converted Shares Have Been Sold FREEHOLD, N.J.,...

ALBT : 0.5150 (-5.50%)
Avalon GloboCare’s Subsidiary Files AI Patent Targeting Compliance-Ready Automated Video Commentary

FREEHOLD, N.J., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT) , a diversified company focused on the development of precision diagnostic...

ALBT : 0.5150 (-5.50%)
Avalon GloboCare Announces FDA Registration Renewal for KetoAir™ and Planned B2B and B2C Launch Through Catch-Up™, Its Automated Generative AI-Powered Short-Form Video SaaS Platform

FREEHOLD, N.J., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT) , a diversified company focused on the development of precision diagnostic...

ALBT : 0.5150 (-5.50%)
Avalon GloboCare Regains Compliance with Nasdaq Stockholders’ Equity Requirement, Launches Marketing for Automated Generative AI Video Platform

FREEHOLD, N.J., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT) , a diversified company focused on the development of precision diagnostic...

ALBT : 0.5150 (-5.50%)
Avalon GloboCare Board Director Highlights RPM Interactive’s Automated Generative AI Video Creation Platform in Interview with ProactiveInvestors.com

FREEHOLD, N.J., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT) , a developer of precision diagnostic consumer products, today announced that...

ALBT : 0.5150 (-5.50%)

Business Summary

Avalon GloboCare Corp. is a clinical-stage biotechnology company. It involved in developing and delivering innovative, transformative cellular therapeutics, precision diagnostics and clinical laboratory services. Avalon GloboCare Corp. is based in FREEHOLD, N.J.

See More

Key Turning Points

3rd Resistance Point 0.7048
2nd Resistance Point 0.6524
1st Resistance Point 0.5987
Last Price 0.5150
1st Support Level 0.4926
2nd Support Level 0.4402
3rd Support Level 0.3865

See More

52-Week High 6.4900
Fibonacci 61.8% 4.1713
Fibonacci 50% 3.4550
Fibonacci 38.2% 2.7387
Last Price 0.5150
52-Week Low 0.4200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.